Disease risk surfaces in rare immune cells, an Ebola outbreak and captive lemurs
Crohn’s risk genes in a rare gut cell, a vaccine-less Ebola strain in DR Congo and fatal herpes transmission to lemurs show vulnerability emerging across very different biological settings.
Science··Morning
Risk genes in a hard-to-reach cell
Cincinnati Children's and the MRC Laboratory of Medical Sciences rebuilt promoter capture Hi-C so that it works on the small numbers of type 3 innate lymphoid cells recoverable from human tonsil. Mapping which distant DNA elements touch which promoters, then reading that map against genome-wide association data, prioritised more than 100 candidate genes for Crohn's disease risk. The peer-reviewed paper in Nature Genetics singles out CLN3, a gene not previously connected to the disease. Its expression drops when the cells are activated, and raising Cln3 levels in mice reduced inflammatory gene activity. The authors state plainly that this does not establish CLN3 as a causal gene in inflammatory bowel disease. Earlier versions of the method needed millions of cells, which kept the cell types most relevant to the disease out of reach. The advance is therefore double: a gene list that includes an unexpected name, and a measurement path into a rare immune compartment that used to sit below the method's detection floor.[1]
An outbreak without a matched vaccine
Tom Fletcher, the UN humanitarian chief, said the Ebola outbreak in the Democratic Republic of Congo has killed at least 2,128 people out of more than 4,500 confirmed cases since it was declared on May 15, and described it as the fastest-growing outbreak on record. The strain is Bundibugyo, for which there is no approved vaccine or treatment; the stockpiles built during earlier Zaire-strain outbreaks do not apply to it. Cases have been reported across 6 provinces, with further cases in Uganda and near the border with South Sudan. Countries have pledged close to 300 million dollars, and the UN has released a further 30.5 million dollars from emergency funds. Here vulnerability is not a gene list but a mismatch between the circulating virus and the medical countermeasures already stocked for a different Ebola species. The reported scale and the absence of a strain-matched tool set the public health frame without turning the numbers into a forecast.[2]
A common human virus in captive lemurs
Veterinary researchers confirmed herpes simplex virus type 1 in 4 privately owned lemurs in the United States. All of them developed brain inflammation and died. It is the first time PCR testing has confirmed the human virus in lemurs; earlier reports relied on other laboratory methods. The cases, reported in the Journal of Zoo and Wildlife Medicine, span 8 years and involve 2 ring-tailed lemurs, 1 black-and-white ruffed lemur and 1 ruffed hybrid. One animal had taken part in a lemur yoga programme; co-author Jim Wellehan of the University of Florida says its infection was almost certainly linked to close contact with people, while the study cannot show that transmission happened in any particular session. Most adults carry the virus without symptoms, which is what makes routine close contact with primates risky. Set beside the Crohn's gene map and the Bundibugyo outbreak, the shared subject is vulnerability that becomes visible only when the right cell, the right strain or the right host contact is finally measured: a rare gut immune cell, an Ebola species without stockpiled vaccines, and a human cold-sore virus lethal in lemurs.[3], [1], [2]
